A Trump Administration aligned think tank outlined policies that could use US Centers for Medicare and Medicaid Services and US Trade Representative authorities to pressure foreign governments to increase the prices paid for drugs while allowing the US to enact Most Favored Nation and international reference pricing policies.
Think Tank Suggests CMS, USTR Could Enforce Most Favored Nation, Other Drug Pricing Policies
A Republican think tank suggested variations of the Most Favored Nation and international reference policies in Medicare and Medicaid, as well as tariffs and other trade levers to rebalance drug pricing disparities between US countries and abroad.
